Unique immune signatures can distinguish rare autoimmune condition from multiple sclerosis

Updated on: December 12,2025

Unique immune signatures can distinguish rare autoimmune condition from multiple sclerosis

Updated on:December 12,2025

FDA defends approval of controversial Alzheimer's drug

by Dennis ThompsonThe U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defendi

Updated on: March 30,2024

FDA defends approval of controversial Alzheimer's drug

by Dennis ThompsonThe U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defendi

Updated on:March 30,2024

Unraveling Alzheimer's catalysts as weavers of amyloid β fibrils

by National Institutes of Natural Sciences(A) On the neuronal cell membrane, Aβ molecules adopt a "U"-shaped conformation, allining alternately on the membrane surface to form two layer

Updated on: July 01,2024

Unraveling Alzheimer's catalysts as weavers of amyloid β fibrils

by National Institutes of Natural Sciences(A) On the neuronal cell membrane, Aβ molecules adopt a "U"-shaped conformation, allining alternately on the membrane surface to form two layer

Updated on:July 01,2024

Nearly one-third of patients with TBI have marginal or inadequate health literacy

by Wolters Kluwer HealthCredit: Wikimedia CommonsLow health literacy is a problem for a substantial proportion of people with moderate to severe traumatic brain injury (TBI),according

Updated on: March 30,2024

Nearly one-third of patients with TBI have marginal or inadequate health literacy

by Wolters Kluwer HealthCredit: Wikimedia CommonsLow health literacy is a problem for a substantial proportion of people with moderate to severe traumatic brain injury (TBI),according

Updated on:March 30,2024

FDA approves much-debated Alzheimer's drug panned by experts

by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio

Updated on: March 30,2024

FDA approves much-debated Alzheimer's drug panned by experts

by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio

Updated on:March 30,2024

Research study validates neuroreader for accurate and fast measurement of brain volumes

by IOS PressDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A new neuroimaging software, Neuroreader, was shown to be as accurate as traditional met

Updated on: February 26,2024

Research study validates neuroreader for accurate and fast measurement of brain volumes

by IOS PressDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A new neuroimaging software, Neuroreader, was shown to be as accurate as traditional met

Updated on:February 26,2024

New approaches to understanding Alzheimer's and Parkinson's disease

by Alzheimer's Research UKIn a study presented today at the Alzheimer's Association International Conference 2016, researchers at the Douglas Mental Health University Institute have explo

Updated on: March 07,2024

New approaches to understanding Alzheimer's and Parkinson's disease

by Alzheimer's Research UKIn a study presented today at the Alzheimer's Association International Conference 2016, researchers at the Douglas Mental Health University Institute have explo

Updated on:March 07,2024

Use of prescription analgesics differs significantly between persons with and without Alzheimer's

by University of Eastern FinlandApproximately one third of persons with Alzheimer's disease use prescription medicines for pain after their diagnosis, reports a recent study conducted at the

Updated on: March 07,2024

Use of prescription analgesics differs significantly between persons with and without Alzheimer's

by University of Eastern FinlandApproximately one third of persons with Alzheimer's disease use prescription medicines for pain after their diagnosis, reports a recent study conducted at the

Updated on:March 07,2024

New imaging technique reveals detailed map of brain's blood flow in 3D

byChinese Academy of SciencesResearch overview. 1. The extended-focus optical coherence microscopy system. 2. The data acquisition and post-processing pipeline. 3. Exemplary results, showing a v

Updated on: November 23,2024

New imaging technique reveals detailed map of brain's blood flow in 3D

byChinese Academy of SciencesResearch overview. 1. The extended-focus optical coherence microscopy system. 2. The data acquisition and post-processing pipeline. 3. Exemplary results, showing a v

Updated on:November 23,2024

Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease

by Bentham Science PublishersDementia and other tauopathies, most notably Alzheimer's disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in th

Updated on: February 28,2024

Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease

by Bentham Science PublishersDementia and other tauopathies, most notably Alzheimer's disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in th

Updated on:February 28,2024

New cases of dementia in the UK fall by 20 percent over two decades

by University of CambridgeThe UK has seen a 20% fall in the incidence of dementia over the past two decades, according to new research from England, led by the University of Cambridge, leading to

Updated on: February 28,2024

New cases of dementia in the UK fall by 20 percent over two decades

by University of CambridgeThe UK has seen a 20% fall in the incidence of dementia over the past two decades, according to new research from England, led by the University of Cambridge, leading to

Updated on:February 28,2024

Alzheimer's disease destroys neurons that keep us awake

by University of California, San FranciscoCredit: CC0 Public DomainResearchers and caregivers have noted that excessive daytime napping can develop long before the memory problems associated with

Updated on: April 10,2024

Alzheimer's disease destroys neurons that keep us awake

by University of California, San FranciscoCredit: CC0 Public DomainResearchers and caregivers have noted that excessive daytime napping can develop long before the memory problems associated with

Updated on:April 10,2024